Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
14,368,296
-
Share change
-
+1,204,719
-
Total reported value
-
$132,185,088
-
Price per share
-
$9.20
-
Number of holders
-
60
-
Value change
-
+$10,383,968
-
Number of buys
-
30
-
Number of sells
-
22
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q1 2020
As of 31 Mar 2020,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,368,296 shares.
The largest 10 holders included
FMR LLC, ARK Investment Management LLC, Capital International Investors, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., CAPITAL INTERNATIONAL INC /CA/, Capital World Investors, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., and CREDIT SUISSE AG/.
This page lists
60
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.